General Questions for Session 1 Participants
Overarching Road Map Issues
is senior scientist at the Children’s Hospital Oakland Research Institute and is a former chair of the FNB.
Dr. Alice Lichtenstein of Tufts University examined the issues in applying systematic evidence-based review (SEBR) approaches to DRI development. Dr. Elizabeth Yetley, a Senior Nutrition Research Scientist with the Office of Dietary Supplements at the National Institutes of Health, discussed whether risk assessment is a relevant organizing structure for the DRI development process.
Designated discussants followed Drs. Russell, Trumbo, and Yates, and a designated discussant engaged Drs. Lichtenstein and Yetley. In each case, the discussions were followed by input from the workshop audience. The session concluded with a panel discussion, at which point the session was again opened to the audience for comment.